病人从昂贵的Mounjaro转向便宜的Wegovy,价格涨幅高达170%。 Patients switch from costly Mounjaro to cheaper Wegovy amid 170% price hike.

在Mounjaro涨价170%之后, 许多病人转往Wegovy, 一种便宜的减肥药物。 Following a 170% price hike for Mounjaro, many patients are switching to Wegovy, a cheaper weight loss medication. Google趋势显示,在这两种药物之间调换的搜索量增加了55.5%。 Google Trends shows a 5,500% increase in searches for switching between the two drugs. 两者均为GLP-1受体激动剂,每周注射原为2型糖尿病设计的注射,但对减肥有效。 Both are GLP-1 receptor agonists, weekly injections originally designed for type 2 diabetes but effective for weight loss. 药剂师建议医生在转诊前先咨询一名保健专业人员,以确保安全和功效。 Pharmacists advise consulting a healthcare professional before switching to ensure safety and efficacy.